Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Dow Jones International Internet UCITS ETF 28.01.2026 FDNI.LN IE00BT9PVG14 400,002.00 USD 9,178,578.08 22.946  ...

SUGAR LAND, Texas--(BUSINESS WIRE)--CVR Energy, Inc. (the “Company” or “CVR Energy”) (NYSE: CVI) announced today that, subject to market conditions, it intends to offer (the “Offering”) for sale in a private placement pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended (the “Securities Act”), $1 billion in aggregate principal amount of senior unsecured notes due 2031 (the “2031 Notes”) and senior unsecured notes due 2034 (the “2034 Notes” and, together with the 2...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 28.01.2026 UIGB IE00079WNSI6 16,334.00 GBP 400,961.49 24.548  ...

DUBLIN--(BUSINESS WIRE)--The "Prepaid Cards Knowledge Center - Online Business Intelligence Platform Offering Data, Analysis, and Opinion on Prepaid Cards" newsletter has been added to ResearchAndMarkets.com's offering. The Prepaid Cards Knowledge Center is an online strategy research platform offering business intelligence on prepaid cards. This platform comprises over 40,000 data points and 400+ reports across 40 countries. The authors unbiased and accurate analysis combines industry level op...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

WEST PALM BEACH, Fla.--(BUSINESS WIRE)--PSQ Holdings, Inc. (NYSE: PSQH) ("PublicSquare" or the "Company"), today announced that Dusty Wunderlich has been appointed CEO, effective immediately, as the Company continues its transition to core fintech businesses, including credit and payments. Mr Wunderlich was recently appointed Chairman of the Board of PublicSquare and will remain in that role. As part of this transition, Michael Seifert has stepped down as Chief Executive Officer and resigned fr...

JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon announces date for Q4 and FY2025 earnings results conference call will be February 12, 2026 at 8:30am EST....

DELHI, India--(BUSINESS WIRE)--1Buy.AI, an AI-first electronics procurement platform, today announced a $3.9 million seed round led by 100Unicorns....

TORONTO--(BUSINESS WIRE)--Docebo Inc. (NASDAQ: DCBO; TSX: DCBO) (“Docebo” or the “Company”), a leading learning platform provider with a foundation in artificial intelligence (AI) and innovation, announced that the board of directors (the “Board”) has approved a substantial issuer bid (the “Offer”) under which the Company will offer to repurchase for cancellation up to US$60,000,000 of its outstanding common shares (“Common Shares”) at a price of US$20.40 per Common Share. In connection with th...

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that the U.S. Food & Drug Administration (FDA) has accepted for filing Summit's Biologics License Application (BLA) seeking approval for ivonescimab in combination with chemotherapy in patients with epidermal growth factor receptor (EGFR)-mutated locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) post-tyrosine kinase inhibitor (TKI) therapy. The FDA...